HTDS provides access to USPTO documents related to its IP ownership rights

Hard to Treat Diseases (the "Company") (HTDS.PK) provides access to U.S. Patent and Trademark Office.("USPTO") documents relating to intellectual property ("IP") ownership rights of the Company.

HTDS management has duly notified the OTCBB company utilizing the IP rights of the Company and is providing its shareholders with certain other "Supplementary" filings made yesterday with Pink Sheets.

The supplementary filings made on Pink Sheets by HTDS include the actual copies of the USPTO recording documents, the letter to the OTCBB Company utilizing HTDS rights and proof of FedEx delivery of the same.

These documents are self explanatory.

HTDS management is of the opinion that this information is material, and both issuers need to disclose its potential effect to its shareholders and investors. The OTCBB company is in default in their filings with the SEC. and has received an "e" on its symbol as a late filing issuer.

HTDS ownership rights for the five patents can be accessed at the following five USPTO websites:

HTDS management will continue to monitor the situation and intends to vigorously escalate its claim to protect its interests. The Company is not ruling out any available options at this point regarding the IP rights that may have a positive significant impact on the entire value of HTDS.

Further updates to follow.

http://www.htdsmedical.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.